BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

NCT06462001 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Transitional Cell Carcinoma
Transurethral Resection

Interventions

BIOLOGICAL: Bacillus Calmette-Guerin Vaccine Intravesical
DRUG: Mitomycin

Sponsor

Nottingham University Hospitals NHS Trust

Collaborators

[object Object]
[object Object]